M&A - BIO-RAD LABORATORIES, INC.

Form Type: 8-K

Filing Date: 2025-02-13

Corporate Action: Acquisition

Type: New

Accession Number: 000001220825000004

Filing Summary: On February 13, 2025, Bio-Rad Laboratories, Inc. announced its financial results for the quarter ending December 31, 2024, and disclosed a strategic restructuring plan affecting its U.S. operations. This involves a workforce reduction of approximately 5%, incurring costs between $45 million and $50 million primarily for employee termination benefits. The restructuring is expected to be substantially completed by the end of fiscal year 2025. Additionally, the company has entered into a binding offer to purchase all equity interests in Stilla Technologies, a French corporation, as announced in a press release dated the same day.

Document Link: View Document